Manufacturer of Controlled Substances; Notice of Registration, 61375-61376 [E7-21323]
Download as PDF
<![CDATA[
sroberts on PROD1PC70 with NOTICES
Federal Register / Vol. 72, No. 209 / Tuesday, October 30, 2007 / Notices
entry of appearance with the Secretary
to the Commission, as provided in
sections 201.11 and 207.10 of the
Commission’s rules, not later than seven
days after publication of this notice in
the Federal Register. Industrial users
and (if the merchandise under
investigation is sold at the retail level)
representative consumer organizations
have the right to appear as parties in
Commission antidumping
investigations. The Secretary will
prepare a public service list containing
the names and addresses of all persons,
or their representatives, who are parties
to this investigation upon the expiration
of the period for filing entries of
appearance.
Limited disclosure of business
proprietary information (BPI) under an
administrative protective order (APO)
and BPI service list. Pursuant to section
207.7(a) of the Commission’s rules, the
Secretary will make BPI gathered in this
investigation available to authorized
applicants representing interested
parties (as defined in 19 U.S.C. 1677(9))
who are parties to the investigation
under the APO issued in the
investigation, provided that the
application is made not later than seven
days after the publication of this notice
in the Federal Register. A separate
service list will be maintained by the
Secretary for those parties authorized to
receive BPI under the APO.
Conference. The Commission’s
Director of Operations has scheduled a
conference in connection with this
investigation for 9:30 a.m. on November
13, 2007, at the U.S. International Trade
Commission Building, 500 E Street SW.,
Washington, DC. Parties wishing to
participate in the conference should
contact Fred Ruggles (202–205–3187/
fred.ruggles@usitc.gov) not later than
November 9, 2007, to arrange for their
appearance. Parties in support of the
imposition of antidumping duties in
this investigation and parties in
opposition to the imposition of such
duties will each be collectively
allocated one hour within which to
make an oral presentation at the
conference. A nonparty who has
testimony that may aid the
Commission’s deliberations may request
permission to present a short statement
at the conference.
Written submissions. As provided in
sections 201.8 and 207.15 of the
Commission’s rules, any person may
submit to the Commission on or before
November 16, 2007, a written brief
containing information and arguments
pertinent to the subject matter of the
investigation. Parties may file written
testimony in connection with their
presentation at the conference no later
VerDate Aug<31>2005
20:46 Oct 29, 2007
Jkt 214001
than three days before the conference. If
briefs or written testimony contain BPI,
they must conform with the
requirements of sections 201.6, 207.3,
and 207.7 of the Commission’s rules.
The Commission’s rules do not
authorize filing of submissions with the
Secretary by facsimile or electronic
means, except to the extent permitted by
section 201.8 of the Commission’s rules,
as amended, 67 FR 68036 (November 8,
2002). Even where electronic filing of a
document is permitted, certain
documents must also be filed in paper
form, as specified in II (C) of the
Commission’s Handbook on Electronic
Filing Procedures, 67 FR 68168, 68173
(November 8, 2002).
In accordance with sections 201.16(c)
and 207.3 of the rules, each document
filed by a party to the investigation must
be served on all other parties to the
investigation (as identified by either the
public or BPI service list), and a
certificate of service must be timely
filed. The Secretary will not accept a
document for filing without a certificate
of service.
Authority: This investigation is being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to section 207.12 of the
Commission’s rules.
Issued: October 25, 2007.
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E7–21300 Filed 10–29–07; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated June 7, 2007, and
published in the Federal Register on
June 20, 2007, (72 FR 34039), Cambrex
Charles City, Inc., 1205 11th Street,
Charles City, Iowa 50616, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Lisdexamfetamine dimesylate (1205), a
basic class of controlled substance listed
in schedule II.
The company plans to manufacture
the listed controlled substance for sale
to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cambrex Charles City, Inc. to
manufacture the listed basic class of
controlled substance is consistent with
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
61375
the public interest at this time. DEA has
investigated Cambrex Charles City, Inc.
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with State
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: October 22, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–21311 Filed 10–29–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated June 7, 2007, and
published in the Federal Register on
June 20, 2007, (72 FR 34039), Cambrex
Charles City, Inc., 1205 11th Street,
Charles City, Iowa 50616, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Oxycodone (9143), a basic class of
controlled substance listed in schedule
II.
The company plans to manufacture
the listed controlled substance for sale
to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cambrex Charles City, Inc. to
manufacture the listed basic class of
controlled substance is consistent with
the public interest at this time. DEA has
investigated Cambrex Charles City, Inc.
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
E:\FR\FM\30OCN1.SGM
30OCN1
61376
Federal Register / Vol. 72, No. 209 / Tuesday, October 30, 2007 / Notices
Dated: October 22, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–21323 Filed 10–29–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Office of the Secretary
Office of Small Business Programs;
Proposed Collection; Comment
Request
AGENCY:
Office of the Secretary, DOL.
Notice; opportunity to comment
on a proposed collection of information.
ACTION:
SUMMARY: The Department of Labor, as
part of its continuing effort to reduce
paperwork and respondent burden,
conducts a pre-clearance consultation
program to provide the general public
and Federal agencies an opportunity to
comment on proposed and/or
continuing collections of information in
accordance with the Paperwork
Reduction Act of 1995 (PRA95) [44
U.S.C. 3506(c)(2)(A)]. This program
helps to ensure that requested data can
be provided in the desired format,
reporting burden (time and financial
resources) is minimized, collection
instruments are clearly understood, and
the impact of collection requirements on
respondents can be properly assessed.
Currently, the Office of Small Business
Programs (OSBP) is soliciting comments
concerning the proposed continuation
of the information collections contained
in the Small Business Programs
Information Management System. A
copy of the proposed information
collection request (ICR) can be obtained
by contacting the employee listed below
in the ADDRESSES Section of this notice.
Written comments must be
submitted to the office listed in the
ADDRESSES Section below on or before
December 31, 2007.
DATES:
Send comments to Brenda
R. Berry, Management Analyst, U.S.
Department of Labor, Office of Small
Business Programs, Room C–2313, 200
Constitution Avenue, NW., Washington,
DC 20210; E-Mail:
berry.brenda@dol.gov; Telephone: 202–
693–6479; Fax: 202–693–6486 (these are
not a toll free numbers).
sroberts on PROD1PC70 with NOTICES
ADDRESSES:
FOR FURTHER INFORMATION CONTACT: The
employee listed above in the ADDRESSES
Section of this notice.
SUPPLEMENTARY INFORMATION:
VerDate Aug<31>2005
20:46 Oct 29, 2007
Jkt 214001
I. Background
Federal agencies are required to
promote procurement opportunities for
small, small disadvantaged, and 8(a)
businesses by the Small Business Act, as
amended, (Public Law 95–507, Sections
8 and 15) and Public Law 100–656
(Sections 502 and 503). The Federal
Acquisition Streamlining Act of 1994
(Pub. L. 103–355) mandates similar
efforts for small women-owned
businesses. Public Law 106–50 created
the program for service-disabled
veteran-owned small businesses. Public
Law 105–135 established the HubZone
program. The Small Business Regulatory
Enforcement Fairness Act of 1996 (Pub.
L. 104–121) requires Federal agencies to
make available to small businesses
compliance guides and assistance on the
implementation of regulations and
directives of enforcement laws they
administer. Executive Orders 13256,
13230, and 13270 direct Federal
agencies to implement programs,
respectively, regarding Historically
Black Colleges and Universities,
Educational Excellence for Hispanic
Americans, and Tribal Colleges and
Universities that are administered by
the respective White House Initiative
offices (in the U.S. Department of
Education). Executive Order 13125
directs Federal agencies to ensure that
Asian Americans and Pacific Islanders
are afforded opportunity to fully
participate in Federal Programs.
Further, Executive Order 13170 requires
that Departments take a number of
actions to increase outreach and
maximize participation of small
disadvantaged businesses in their
procurements. Executive Order 13157
strengthens the executive branch’s
commitment to increased opportunities
for women-owned small businesses.
Accordingly, the Small Business
Programs Information Management
System is needed to gather, document,
and manage identifying information for
four Office of Small Business Programs
constituency groups: Small Businesses;
Trade Associations; Minority Colleges
and Universities; and Tribal
Governments. Via this system, the
constituent groups will have the
opportunity to voluntarily provide to
OSBP information about their
organizations. The information will be
used by OSBP and DOL agencies to
maximize communication with the
respective constituency groups
regarding relevant OSBP and DOL
programs, initiatives, and procurement
opportunities; to track and solicit
feedback on customer service to group
members; and to facilitate registration of
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
group members for OSBP-sponsored
activities.
II. Review Focus
The Office of Small Business
Programs is particularly interested in
comments which:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
III. Current Actions
Currently, the Office of Small
Business Programs (OSBP) is soliciting
comments concerning the proposed
continuation of the information
collections contained in the Small
Business Programs Information
Management System. The estimated
public burden associated with this
collection of information is summarized
below:
Type of Review: Extension of a
currently approved collection.
Agency: Office of Small Business
Programs.
Title: Small Business Program
Information Management System.
OMB Number: 1290–0002.
Agency Form Number: None.
Affected Public: Business or other forprofit; Not-for-profit institutions; and
State, Local, or Tribal Governments.
Estimated Total Annual Respondents:
500.
Estimated Total Annual Responses:
1,000.
Frequency: On Occasion.
Estimated Average Time Per
Response: 5–7 minutes.
Estimated Total Annual Burden
Hours: 160 hours.
Total Burden Cost (capital/startup):
$0.
Total Burden Cost (operating/
maintenance): $0.
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget approval of the
E:\FR\FM\30OCN1.SGM
30OCN1
]]>Agencies
[Federal Register Volume 72, Number 209 (Tuesday, October 30, 2007)]
[Notices]
[Pages 61375-61376]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-21323]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 7, 2007, and published in the Federal Register
on June 20, 2007, (72 FR 34039), Cambrex Charles City, Inc., 1205 11th
Street, Charles City, Iowa 50616, made application by letter to the
Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of Oxycodone (9143), a basic class of controlled substance
listed in schedule II.
The company plans to manufacture the listed controlled substance
for sale to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cambrex Charles City, Inc. to manufacture the listed basic class of
controlled substance is consistent with the public interest at this
time. DEA has investigated Cambrex Charles City, Inc. to ensure that
the company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
[[Page 61376]]
Dated: October 22, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-21323 Filed 10-29-07; 8:45 am]
BILLING CODE 4410-09-P
